Long-term efficient gene delivery using polyethylenimine with modified Tat peptide.

Area of Science:

• Biotechnology
• Gene Therapy
• Nanomedicine

Background:

• Polyethylenimine (PEI) is a promising cationic polymer for gene delivery.
• HIV-1 Tat peptide facilitates intracellular delivery.
• Combining these vectors aims to enhance gene delivery properties.

Purpose of the Study:

• To develop and evaluate a novel gene delivery vector by combining PEI with a modified Tat peptide (mTat).
• To assess the in vitro and in vivo transfection efficiency and cytotoxicity of the mTat/PEI complex.

Main Methods:

• mTat/PEI/DNA complexes were formed and characterized for particle size.
• In vitro transfection efficiency was measured using luciferase expression in two cell lines.
• In vivo gene expression was evaluated in animals following intramuscular administration.

Main Results:

• mTat/PEI significantly improved transfection efficiency (≈5-fold) compared to individual components or commercial reagents, with low cytotoxicity.
• Smaller particle size of mTat/PEI/DNA correlated with higher transfection efficiency.
• Caveolae-mediated endocytosis was identified as the primary cellular uptake mechanism.
• In vivo studies showed sustained luciferase expression (≈7 months) with no observed toxicity.

Conclusions:

• The combination of mTat and PEI creates a highly efficient non-viral gene delivery vector.
• This novel vector demonstrates significant potential for both in vitro and in vivo gene therapy applications.